ProCE Banner Activity

Advances in IBD Management: My Take on Data From Crohn’s and Colitis Congress 2021

Conference Coverage
Clinical Thought
In this commentary, I present my take on interesting new data from the 2021 virtual Crohn’s & Colitis Congress on the relationship between visceral adipose tissue and outcomes for patients with IBD and the role of diet in IBD management.

Released: March 05, 2021

Expiration: March 04, 2022

Share

Faculty

Anita Afzali

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Professor of Clinical Medicine
Division of Digestive Diseases
Executive Vice Chair, Department of Internal Medicine
Associate Chief Medical Officer
University of Cincinnati, UC Health System
Cincinnati, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AbbVie

Faculty Disclosure

Primary Author

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Professor of Clinical Medicine
Division of Digestive Diseases
Executive Vice Chair, Department of Internal Medicine
Associate Chief Medical Officer
University of Cincinnati, UC Health System
Cincinnati, Ohio

Anita Afzali, MD, MPH, FACG, has disclosed that she has received consulting fees from AbbVie, Bristol-Myers Squibb/Celgene, Gilead Sciences, Janssen, Lilly, Pfizer, and Takeda.